Newly Scheduled Novel Psychoactive Substances

By Kevin Shanks, M.S., D-ABFT-FT Novel psychoactive substances (NPS) are compounds designed or consumed to mimic the effects of typical recreational substances such as diacetylmorphine (heroin), cocaine, methamphetamine, cannabis, or even prescription medications. As...

Cannabinoids Panel Update

Dear Valued Client, In the spirit of continuous improvement, to provide the most relevant panels and tests in the industry, our products are periodically updated to provide new and relevant offerings. It is with that goal in mind that we announce an update to our...

Xylazine Presentation at MATT Conference 2023

By Stuart Kurtz, D-ABFT-FT In April, I spoke at the Midwest Association of Toxicology and Therapeutic Drug Monitoring (MATT) annual conference in Columbus, OH. The title of the talk was “Detection of Xylazine in Postmortem Specimens With Fentanyl, Morphine,...

Vitreous Chemistries, part 2.

By Stuart Kurtz, M.S. D-ABFT-FT As discussed in the previous blog post, vitreous humor has many caveats when interpreting its results in the context of postmortem toxicology. For those considerations and some background on vitreous humor, check out that post first...

Vitreous Chemistries, part 1.

By Stuart Kurtz, M.S. D-ABFT-FT The purpose of these next two blog posts is to discuss the utility that vitreous humor provides in the context of a case. This first post will focus on what vitreous humor is and the caveats associated with its interpretation. The...

Axis – Experts on Xylazine

By Denise Purdie Andrews Recent industry news has been consumed with xylazine as the latest drug adulterant on the streets.  Axis, your leading toxicology partner, has been testing for xylazine for several years and is prepared to assist you with questions about it...